Due to a lack of high-quality trials to guide management of CRPS, there is no single recommended treatment. This can result in patients being driven to seek dangerous and ineffective treatments, such as ketamine-induced coma or amputation, which can lead to substantial harms including death.
To help address this issue, researchers from the Centre for Pain IMPACT at NeuRA (Neuroscience Research Australia), will be starting a randomised controlled trial in 2020 for people with CRPS. This trial will be testing a promising new intervention that targets the brain and central nervous system to help reduce pain and disability of people with CRPS.
If you are interested in finding out further information about our research, please visit our website and leave your details. We will contact you when the trial begins.
For more information about Colour The World Orange, please visit: https://www.colortheworldorange.com